Clinial Application of Park et al.(The Knee 27 (2020) 1577-1584)'s Study
WithdrawnNot applicableNCT05202847
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this study was to perform pulsed radiofrequency ablation with a modified target suggested in the cadaver study by Park et al. (The Knee 27 (2020) 1577-1584) on knee osteoarthritis patients, and to evaluate the effect of reducing the frequency of intravascular injection and reducing pain.
Study details
- Official title
- Pulsed Radiofrequency Ablation to the Modified Ablation Points for Chronic Knee Pain Due to Osteoarthritis: Preliminary Prospective Randomized Controlled Study
- Conditions
- Interventions
- Procedure: pulsed radiofrequency ablation to modifined points group
- Procedure: pulsed radiofrequency ablation to conventional points group
- Sponsor
- Gangnam Severance Hospital
- Start date
- 2022-12-07
- Primary completion
- 2022-12-07
- Sex
- All
- Age range
- from 19 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. chronic knee pain that does not respond to conservative treatment (physiotherapy, oral analgesic, steroid intra-articular injection, Hyruan injection) for more than 6 months 2. A score of 6 or higher (out of 10) on the target knee's numerical rating scale 3. Knee osteoarthritis 1-4 confirmed in knee X ray within 6 months of study enrollment Exclusion Criteria: 1. Systemic inflammatory diseases such as rheumatic diseases 2. uncontrolled diabetes 3. malignant tumor 4. If the target knee has a previous surgical history (arthroscopy, arthroscopy, autologous or allograft osteochondral transplantation and autologous cartilage cell transplantation, osteotomy, arthritis surgery) 5. Patients with lidocaine and contrast agent allergy 6. history of nerve block in the target knee within 2 weeks 7. Body mass index over 40 kg/m2 8. bleeding disorder 9. Pregnant/lactating women 10. Inability to understand informed consent and respond to research questionnaires due to cognitive impairment 11. Unable to read consent form (e.g. illiterate, foreigner, etc.)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05202847